Scholarlink

Objective <p>Our study was aimed to established imaging models that can predict the prognosis of breast cancer patients based on IL18, so as to facilitate the formulation of more individualized treatment plans during the treatment.</p> Method <p>We established enhancing MRI models to predict the mRNA expression of IL18 in breast cancer tissues. Meanwhile, bioinformatics analysis was integrated to studied the expression of IL18 in breast cancer with its clinical significance to explore the potential molecular mechanisms and its association with the immune microenvironment.</p> Result <p>In breast cancer patients, high levels of IL18 expression are associated with improved overall survival (OS), and natural killer cells (NK cells) significantly increased (<i>P</i> &lt; 0.001) with elevated IL18. Three radiomics models, RFE-GBM, Relief-GBM, and RFE_Relief-GBM were established in our study, each model demonstrated strong predictive consistency in the prognosis of breast cancer patients.</p> Conclusion <p>IL18 is a protective factor in breast cancer, our radiomics models can serve as valuable non-invasive tools for utilizing mRNA expression of IL18 by enhancing MRI and show promise in predicting prognosis of breast cancer patients.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Radiomic imaging models for predicting breast cancer prognosis based on Interleukin-18 (IL18)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月12日

查看全文
  • Qian Zhou,
  • Mie Chen,
  • Xiahui Ye,
  • Jie Wang,
  • Xun Lu,
  • Wenjie Shi,
  • Cheng Lu,
  • Hong Yin

摘要

Objective

Our study was aimed to established imaging models that can predict the prognosis of breast cancer patients based on IL18, so as to facilitate the formulation of more individualized treatment plans during the treatment.

Method

We established enhancing MRI models to predict the mRNA expression of IL18 in breast cancer tissues. Meanwhile, bioinformatics analysis was integrated to studied the expression of IL18 in breast cancer with its clinical significance to explore the potential molecular mechanisms and its association with the immune microenvironment.

Result

In breast cancer patients, high levels of IL18 expression are associated with improved overall survival (OS), and natural killer cells (NK cells) significantly increased (P < 0.001) with elevated IL18. Three radiomics models, RFE-GBM, Relief-GBM, and RFE_Relief-GBM were established in our study, each model demonstrated strong predictive consistency in the prognosis of breast cancer patients.

Conclusion

IL18 is a protective factor in breast cancer, our radiomics models can serve as valuable non-invasive tools for utilizing mRNA expression of IL18 by enhancing MRI and show promise in predicting prognosis of breast cancer patients.

Clinical trial number

Not applicable.